Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 244

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 244
---
 for which deferred tax assets were not recognized were JPY 65,232 447,645

The aggregate amounts of temporary differences associated with investments in subsidiaries for which deferred tax liabilities were not recognized were JPY 532,960 578,601

Changes in the amounts of unrecognized deferred tax assets and liabilities associated with investments in subsidiaries are primarily due to changes in temporary differences that had no impact on the consolidated statements of profit or loss.

8. Earnings per Share

The basis for calculating basic and diluted earnings per share (“ EPS”) (attributable to owners of the Company) is as follows:

                                                                                                              For the Year Ended March 31                                                                     
                                                                                                                                     2023                      2024                      2025                 
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Net profit for the year attributable to owners of the Company:                                                                                                                                              
  Net profit for the year attributable to owners of the Company JPY (millions)                                                          ¥        317,017          ¥        144,067          ¥        107,928  
  Net profit used for calculation of earnings per share JPY (millions)                                                                           317,017                   144,067                   107,928  
  Weighted-average number of ordinary shares outstanding during the year (thousands of shares) [basic]                                         1,551,809                 1,564,450                 1,578,873  
  Dilutive effect (thousands of shares)                                                                                                           18,064                    15,893                    26,450  
  Weighted-average number of ordinary shares outstanding during the year (thousands of shares) [diluted]                                       1,569,872                 1,580,343                 1,605,323  
  Earnings per share                                                                                                                                                                                          
  Basic (JPY)                                                                                                                      204.29                     92.09                     68.36                 
  Diluted (JPY)                                                                                                                    201.94                     91.16                     67.23                 

Basic EPS is calculated by dividing the net profit for the year attributable to owners of the Company, with the weighted average number of ordinary shares outstanding during the year. This calculation excludes the average number of treasury shares. Diluted EPS is calculated by dividing the net profit for the year attributable to owners of the Company, with the weighted-average number of ordinary shares outstanding during the year plus the weighted-average